When patients are diagnosed with rectal cancer, they undergo surgery to remove the tumor and, in doing so, a section of the rectum is also removed. In order to eliminate waste normally, an anastomosis is performed, i.e. the remaining healthy parts of the colon are reconnected. One of the major adverse events that can take place following this surgery is an anastomotic leakage, to prevent this a temporary ileostomies used to reduce the risk of anastomotic leakage. Once the rectum has healed from the tumor removal, the ileostomy may be reversed. We have developed CTI, to be used in tube ileostomy, as alternative of the current practices. After the rectal tumor is removed during surgery, CTI is implanted in order to perform a tube ileostomy. Since CTI can be used instead of a loop ileostomy, a stoma does not need to be created and the complications associated with it are avoided. Approximately 8–11 days after implanting CTI, it is can be removed and discharged. By using CTI can save the health care system 30% of direct cost and within the Eu this translate to about €330M. More importantly using CTI will provide patients better health outcomes because they have faster recovery and lower risk of infection.